An IntraHealth International Production
Laneta Dorflinger is the director of contraceptive technology innovation at FHI 360. She has been involved in contraceptive technology development and evaluation for over 30 years and is a passionate advocate for expanding reproductive choice. She currently leads initiatives to develop and introduce new mid- to long‐acting contraceptive methods. Prior to her current position at FHI 360, Laneta directed the Preventive Technologies Agreement – a USAID‐funded global program to characterize safety and effectiveness of microbicides and oral pre‐exposure prophylaxis, expand understanding of the interface between prevention technology and behavior, and improve service delivery models for integration of family planning and HIV. She also worked at USAID where she focused on the development, introduction, and assessments of contraceptive technology.